Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: In vitro fecal fermentation of resistant starch

PROVIDER: PRJNA682640 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13200600_1.fastq.gz	Fastqsanger.gz
	SRR13200600_2.fastq.gz	Fastqsanger.gz
	SRR13200700_1.fastq.gz	Fastqsanger.gz
	SRR13200700_2.fastq.gz	Fastqsanger.gz
	SRR13200601_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 278

Similar Datasets

Project description:fecal fermentation in vitro

| PRJNA957265 | ENA

Project description:In vitro fecal fermentation

| PRJNA740098 | ENA

Project description:Fecal microbiota in vitro fermentation

| PRJNA609248 | ENA

Project description:In vitro gut microbiome response to resistant starch

| PRJNA675102 | ENA

The effect of Synbiotics in humans on biomarkers of risk for colorectal cancer (CRC)

Project description:Interventions: The aim of this study is to test the capacity of a synbiotic (Hi-maize resistant starch + Bifidobacteria) administered in the diet to humans for improving the biomarkers associated with bowel health and reducing the potential risk of colorectal cancer. We will enlist 20 people in a random cross over design with an initial wash out period of 4 weeks (with no consumption of ‘over the counter’ products of Resistant Starch or Bifidobacteria) followed by three treatment phases, using the following variables: Synbiotic – resistant starch (RS) + Bifidobacteria. 4 wks Probiotic only – Bifidobacteria. 4 wks Prebiotic only - resistant starch. 4 wks Primary outcome(s): Rectal epithelium: Histological analysis of rectal epithelial which includes proliferation, apoptosis, cellularity, DNA adducts, MGMTase activity & DNA methylation.[Rectal pinch biopsy will be taken at the end (fourth week) of the initial wash out phase and during the fourth week of each intervention (treatment phase).];Plasma: Measurement of short chain fatty acids (acetate, propionate and butyrate), blood DNA & serum cytokines.[Blood samples will be taken at the end (fourth week) of the initial wash out phase and during the fourth week of each intervention (treatment phase).];Faeces: 24 hour faecal samples for measures including carbohydrate fermentation products (short chain fatty acids), & microflora profile.[faecal specimens will be taken at the end (fourth week) of the initial wash out phase and during the fourth week of each intervention (treatment phase).] Study Design: Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Crossover;Type of endpoint: Efficacy

| 2452713 | ecrin-mdr-crc

Project description:Human fecal in vitro fermentation of pulses

| PRJNA683649 | ENA

bovine gut metagenome

Project description:Analysis of the rumen microbiotawih resistant starch-degrading bacteria fermentation

| PRJDB6529 | ENA

Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors

Project description:This phase II, randomized pilot trial studies the effect of the consumption of foods made with resistant starch compared to foods made with corn starch on biomarkers that may be related to colorectal cancer progression in stage I-III colorectal cancer survivors. Foods made with resistant starch may beneficially influence markers of inflammation, insulin resistance, and the composition of gut bacteria in colorectal cancer survivors.

| 2292640 | ecrin-mdr-crc

Project description:In vitro human fecal fermentation with dietary glycoproteins

| PRJNA984714 | ENA

human gut metagenome

Project description:In vitro batch fecal fermentation Targeted Locus (Loci)

| PRJNA285930 | ENA